210 related articles for article (PubMed ID: 16312948)
21. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
22. Biological removal of pharmaceuticals and personal care products during laboratory soil aquifer treatment simulation with different primary substrate concentrations.
Onesios KM; Bouwer EJ
Water Res; 2012 May; 46(7):2365-75. PubMed ID: 22374299
[TBL] [Abstract][Full Text] [Related]
23. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes.
Gao P; Ding Y; Li H; Xagoraraki I
Chemosphere; 2012 Jun; 88(1):17-24. PubMed ID: 22494528
[TBL] [Abstract][Full Text] [Related]
24. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater.
Kreuzinger N; Clara M; Strenn B; Vogel B
Water Sci Technol; 2004; 50(2):221-8. PubMed ID: 15344795
[TBL] [Abstract][Full Text] [Related]
25. Temporal evolution in PPCP removal from urban wastewater by constructed wetlands of different configuration: a medium-term study.
Reyes-Contreras C; Hijosa-Valsero M; Sidrach-Cardona R; Bayona JM; Bécares E
Chemosphere; 2012 Jun; 88(2):161-7. PubMed ID: 22436587
[TBL] [Abstract][Full Text] [Related]
26. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation and adsorption of pharmaceutical and personal care products by activated sludge after correcting matrix effects.
Deng Y; Li B; Yu K; Zhang T
Sci Total Environ; 2016 Feb; 544():980-6. PubMed ID: 26706769
[TBL] [Abstract][Full Text] [Related]
28. Behaviour of pharmaceuticals and personal care products in constructed wetland compartments: Influent, effluent, pore water, substrate and plant roots.
Hijosa-Valsero M; Reyes-Contreras C; Domínguez C; Bécares E; Bayona JM
Chemosphere; 2016 Feb; 145():508-17. PubMed ID: 26702554
[TBL] [Abstract][Full Text] [Related]
29. Biofiltration of wastewater treatment plant effluent: effective removal of pharmaceuticals and personal care products and reduction of toxicity.
Reungoat J; Escher BI; Macova M; Keller J
Water Res; 2011 Apr; 45(9):2751-62. PubMed ID: 21450327
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
31. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast.
Gómez MJ; Martínez Bueno MJ; Lacorte S; Fernández-Alba AR; Agüera A
Chemosphere; 2007 Jan; 66(6):993-1002. PubMed ID: 16962638
[TBL] [Abstract][Full Text] [Related]
32. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
33. Occurrence and behavior of pharmaceuticals, steroid hormones, and endocrine-disrupting personal care products in wastewater and the recipient river water of the Pearl River Delta, South China.
Yu Y; Huang Q; Wang Z; Zhang K; Tang C; Cui J; Feng J; Peng X
J Environ Monit; 2011 Apr; 13(4):871-8. PubMed ID: 21424011
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA.
Boyd GR; Palmeri JM; Zhang S; Grimm DA
Sci Total Environ; 2004 Oct; 333(1-3):137-48. PubMed ID: 15364525
[TBL] [Abstract][Full Text] [Related]
35. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
[TBL] [Abstract][Full Text] [Related]
36. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants.
Clara M; Kreuzinger N; Strenn B; Gans O; Kroiss H
Water Res; 2005 Jan; 39(1):97-106. PubMed ID: 15607169
[TBL] [Abstract][Full Text] [Related]
37. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
38. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process.
Urase T; Kikuta T
Water Res; 2005 Apr; 39(7):1289-300. PubMed ID: 15862328
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment.
Nakada N; Tanishima T; Shinohara H; Kiri K; Takada H
Water Res; 2006 Oct; 40(17):3297-303. PubMed ID: 16938339
[TBL] [Abstract][Full Text] [Related]
40. Removal of selected pharmaceuticals, personal care products and artificial sweetener in an aerated sewage lagoon.
Hoque ME; Cloutier F; Arcieri C; McInnes M; Sultana T; Murray C; Vanrolleghem PA; Metcalfe CD
Sci Total Environ; 2014 Jul; 487():801-12. PubMed ID: 24393598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
